Elcarte, Myeth A.

HRN: 20-83-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2026
CEFUROXIME 750MG (VIAL)
06/14/2026
06/21/2026
IV
750 MG
Q8HRS
TOTAL THYROIDECTOMY
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines